Effect of polo-like kinase 1 gene silence on cell cycle and drug resistance in K562/A02 cell

被引：5
作者：
Liu, L [1 ]
Zou, P [1 ]
Zhang, M [1 ]
Tian, L [1 ]
Liu, F [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Union Hosp, Wuhan 430022, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2006年 / 119卷 / 07期
关键词：
RNA interference; polo-like kinase 1; K562/A02; cell cycle; drug resistance;
D O I：
10.1097/00029330-200604010-00016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：605 / 608
页数：4
相关论文
共 10 条
[1]   Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation [J].
Ando, K ;
Ozaki, T ;
Yamamoto, H ;
Furuya, K ;
Hosoda, M ;
Hayashi, S ;
Fukuzawa, M ;
Nakagawara, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25549-25561
[2]  
Dai Wei, 2003, Prog Cell Cycle Res, V5, P327
[3]   Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells [J].
Lindon, C ;
Pines, J .
JOURNAL OF CELL BIOLOGY, 2004, 164 (02) :233-241
[4]   Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells [J].
Liu, XQ ;
Erikson, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :5789-5794
[5]   Structure and function of Polo-like kinases [J].
Lowery, DM ;
Lim, D ;
Yaffe, MB .
ONCOGENE, 2005, 24 (02) :248-259
[6]   Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells [J].
Peng, Z ;
Xiao, ZJ ;
Wang, Y ;
Liu, P ;
Cai, YL ;
Lu, SH ;
Feng, WL ;
Han, ZC .
CANCER GENE THERAPY, 2004, 11 (11) :707-712
[7]   Polo-like kinases (Plks) and cancer [J].
Takai, N ;
Hamanaka, R ;
Yoshimatsu, J ;
Miyakawa, I .
ONCOGENE, 2005, 24 (02) :287-291
[8]  
Tan Yao-hong, 2004, Zhonghua Zhongliu Zazhi, V26, P328
[9]   Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage [J].
Tsvetkov, L ;
Stern, DF .
CELL CYCLE, 2005, 4 (01) :166-171
[10]   Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer [J].
Wolf, G ;
Elez, R ;
Doermer, A ;
Holtrich, U ;
Ackermann, H ;
Stutte, HJ ;
Altmannsberger, HM ;
RubsamenWaigmann, H ;
Strebhardt, K .
ONCOGENE, 1997, 14 (05) :543-549
1